Treatment of severe refractory erythema nodosum leprosum with tumor necrosis factor inhibitor Etanercept

Treatment of severe refractory erythema nodosum leprosum with tumor necrosis factor inhibitor Etanercept

Erythema nodosum leprosum (ENL) is a common complication of lepromatous leprosy. Some patients unresponsive to conventional, first-line therapeutics develop recurrent, recalcitrant ENL. Here, we report a case of severe refractory ENL that was successfully treated with Etanercept. Biologics may be co...

Full description

Bibliographic Details
Main Authors: Sundeep Chowdhry, Akhilesh Shukla, Paschal D'souza, Tapan Dhali, Prashansa Jaiswal
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2016-01-01
Series:International Journal of Mycobacteriology
Subjects:
Biologics
Etanercept
Erythema nodosum leprosum
Leprosy
Treatment
Online Access:http://www.ijmyco.org/article.asp?issn=2212-5531;year=2016;volume=5;issue=2;spage=223;epage=225;aulast=Chowdhry

Internet

http://www.ijmyco.org/article.asp?issn=2212-5531;year=2016;volume=5;issue=2;spage=223;epage=225;aulast=Chowdhry

Similar Items